基于血清可溶性T细胞免疫球蛋白及黏蛋白结构域蛋白3构建重症急性胰腺炎预测模型
该回顾性队列纳入2020年6月1日至2022年6月30日常州市第一人民医院与常州市第二人民医院收治的99例AP患者,非SAP组80例、SAP组19例。多因素Logistic回归显示HR(OR=1.059,95%CI 1.010-1.110,P=0.017)、DBil(OR=0.981,95%CI 0.950-0.997,P=0.043)、sTIM3(OR=1.002,95%CI 1.001-1.003,P=0.027)为AP进展为SAP的独立危险因素。据此构建模型:Logit(P)=-14.602+0.187×BMI+0.057×HR+0.006×CRP-0.020×DBil+0.002×sTIM3。ROC分析显示模型AUC 0.957(95%CI 0.913-1.000)优于IL-6的0.902(95%CI 0.845-0.958),P<0.05。
要点
- 多因素回归显示HR(OR=1.059,95%CI 1.010-1.110,P=0.017)、DBil(OR=0.981,95%CI 0.950-0.997,P=0.043)、sTIM3(OR=1.002,95%CI 1.001-1.003,P=0.027)为AP进展为SAP的独立危险因素。
- sTIM3预测模型Logit(P)=-14.602+0.187×BMI+0.057×HR+0.006×CRP-0.020×DBil+0.002×sTIM3。
- 模型预测AP进展为SAP的AUC为0.957(95%CI 0.913-1.000),优于IL-6的0.902(95%CI 0.845-0.958),P<0.05。
- SAP组ICU住院天数1.0(0,1.5)天 vs 非SAP组0(0,0)天,总住院天数17.11±9.39天 vs 8.40±3.08天,均P<0.01。
- SAP组BMI、饮酒史比例、HR、RR、WBC、RBC、CRP、ALT、SCr、PCT、IL-6、sTIM3、BISAP评分、APACHE II评分、MCTSI评分较非SAP组显著升高,SpO2、DBil、IL-10显著降低。
适用人群与场景
- 2020年6月1日至2022年6月30日收治于常州市第一人民医院与常州市第二人民医院的急性胰腺炎(AP)患者,共99例,非SAP组80例、SAP组19例。
- 按住院期间病情进展分为非SAP组(轻症AP和中度重症AP)与SAP组(重症急性胰腺炎)。
诊断标准与关键阈值
- 采用床旁急性胰腺炎严重度指数(BISAP)、急性生理学与慢性健康状况评分II(APACHE II)、改良CT严重指数(MCTSI)于入院48小时内评估。
- 以住院期间是否进展为重症急性胰腺炎(SAP)作为分组标准。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入99例AP患者,非SAP组80例、SAP组19例。
- 与未进展为SAP的患者相比,进展为SAP的患者BMI、饮酒史比例、心率、呼吸频率、白细胞计数、红细胞计数、C反应蛋白、丙氨酸转氨酶、血清肌酐、降钙素原、白介素-6、sTIM3、BISAP评分、APACHE II评分、MCTSI评分显著升高,脉搏血氧饱和度、直接胆红素、白介素-10显著降低。
- SAP组ICU住院天数1.0(0,1.5)天 vs 非SAP组0(0,0)天,总住院天数17.11±9.39天 vs 8.40±3.08天,均P<0.01。
- 多因素Logistic回归显示心率(OR=1.059,95%CI 1.010-1.110,P=0.017)、直接胆红素(OR=0.981,95%CI 0.950-0.997,P=0.043)、sTIM3(OR=1.002,95%CI 1.001-1.003,P=0.027)为AP进展为SAP的独立危险因素。
- 基于sTIM3构建的SAP预测模型:Logit(P)=-14.602+0.187×BMI+0.057×HR+0.006×CRP-0.020×DBil+0.002×sTIM3。
- ROC曲线分析显示,在上述单因素定量指标中,IL-6对AP患者住院期间进展为SAP的预测效果最好,但基于sTIM3的预测模型预测效能显著优于IL-6[AUC及95%CI:0.957(0.913-1.000)vs 0.902(0.845-0.958),P<0.05]。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为基于血清sTIM3的模型对AP患者进展为SAP具有良好的预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the predictive value of the model based on soluble T cell immunogloblulin and mucin domain-containing protein 3 (sTIM3) for the progression of severe acute pancreatitis (SAP) in patients with acute pancreatitis (AP).
METHODS: A retrospective cohort study was conducted. The AP patients admitted to Changzhou First People's Hospital and Changzhou Second People's Hospital from June 1, 2020 to June 30, 2022 were enrolled. Mild AP (MAP) and moderately severe AP (MSAP) patients were classified as non-SAP group, and SAP patients were classified as SAP group according to the progression of AP patients during hospitalization. The basic data, blood biological indicators, serum sTIM3 level, bedside index for severity in acute pancreatitis (BISAP), acute physiology and chronic health evaluation II (APACHE II) score, modified computed tomography severity index (MCTSI) score within 48 hours of admission, and prognosis indicators were collected. Multivariate Logistic regression analysis was conducted to analyze the risk factors of the progression of SAP in patients with AP during hospitalization. Based on the results of multivariate analysis and the best parameters selected based on the minimal Akaike information criterion (AIC), the SAP prediction model based on sTIM3 was constructed. The receive operator characteristic curve (ROC curve) was plotted to analyze the predictive efficacy of the model.
RESULTS: A total of 99 AP patients were enrolled, 80 patients in the non-SAP group and 19 patients in the SAP group. Compared with the non-SAP group, body mass index (BMI), drinking history ratio, heart rate (HR), respiration rate (RR), white blood cell count (WBC), red blood cell count (RBC), C-reactive protein (CRP), alanine aminotransferase (ALT), serum creatinine (SCr), procalcitonin (PCT), interleukin-6 (IL-6), sTIM3, BISAP score, APACHE II score and MCTSI score were significantly increased, and pulse oxygen saturation (SpO2), direct bilirubin (DBil) and IL-10 were significantly decreased. The length of intensive care unit (ICU) stay and total length of hospital stay of patients in the SAP group were significantly longer than those in the non-SAP group [length of ICU stay (days): 1.0 (0, 1.5) vs. 0 (0, 0), total length of hospital stay (days): 17.11±9.39 vs. 8.40±3.08, both P < 0.01]. Multivariate Logistic regression analysis showed that HR [odds ratio (OR) = 1.059, 95% confidence interval (95%CI) was 1.010-1.110, P = 0.017], DBil (OR = 0.981, 95%CI was 0.950-0.997, P = 0.043), and sTIM3 (OR = 1.002, 95%CI was 1.001-1.003, P = 0.027) were independent risk factors for predicting the progression of SAP in patients with AP, and the SAP prediction model based on sTIM3 was constructed: Logit(P) = -14.602+0.187×BMI+0.057×HR+0.006×CRP-0.020×DBil+0.002×sTIM3. ROC curve analysis showed that among the aforementioned single factor quantitative indicators, IL-6 was the most effective in predicting the progression of AP patients to SAP during hospitalization, but the predictive performance of prediction model based on the sTIM3 was significantly better than IL-6 [area under the ROC curve (AUC) and 95%CI: 0.957 (0.913-1.000) vs. 0.902 (0.845-0.958), P < 0.05].
CONCLUSIONS: The model based on serum sTIM3 demonstrated good predictive value for the progression of SAP in patients with AP.
参考来源
- Zhu M, Wang D, Wang W, et al. [Construction of prediction model of severe acute pancreatitis based on serum soluble T cell immunogloblulin and mucin domain-containing protein 3]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38404275. doi:10.3760/cma.j.cn121430-20230128-00041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。